Todd D Armstrong

Research Associate

1992 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Todd D Armstrong is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Effects of B cell-activating factor on tumor immunity

Yarchoan, M., Ho, W. J., Mohan, A., Shah, Y., Vithayathil, T., Leatherman, J., Dennison, L., Zaidi, N., Ganguly, S., Woolman, S., Cruz, K., Armstrong, T. D. & Jaffee, E. M., May 21 2020, In : JCI Insight. 5, 10

Research output: Contribution to journalArticle

Open Access
  • Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Development

    Chu, N. J., Anders, R. A., Fertig, E., Cao, M., Hopkins, A. C., Keenan, B. P., Popovic, A., Armstrong, T. D., Jaffee, E. M. & Zimmerman, J. W., Jul 1 2020, In : Cancer prevention research (Philadelphia, Pa.). 13, 7, p. 569-582 14 p.

    Research output: Contribution to journalArticle

  • Nanoparticle interactions with immune cells dominate tumor retention and induce T cell–mediated tumor suppression in models of breast cancer

    Korangath, P., Barnett, J. D., Sharma, A., Henderson, E. T., Stewart, J., Yu, S. H., Kandala, S. K., Yang, C. T., Caserto, J. S., Hedayati, M., Armstrong, T. D., Jaffee, E., Gruettner, C., Zhou, X. C., Fu, W., Hu, C., Sukumar, S., Simons, B. W. & Ivkov, R., 2020, In : Science Advances. 6, 13, eaay1601.

    Research output: Contribution to journalArticle

    Open Access
  • A CD40 Agonist and PD-1 Antagonist Antibody Reprogram the Microenvironment of Nonimmunogenic Tumors to Allow T-cell–Mediated Anticancer Activity

    Ma, H. S., Poudel, B., Torres, E. R., Sidhom, J. W., Robinson, T. M., Christmas, B., Scott, B., Cruz, K., Woolman, S., Wall, V. Z., Armstrong, T. & Jaffee, E. M., Mar 2019, In : Cancer Immunology Research. 7, 3, p. 428-442 15 p.

    Research output: Contribution to journalArticle

  • Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies

    Kim, V. M., Blair, A. B., Lauer, P., Foley, K., Che, X., Soares, K., Xia, T., Muth, S. T., Kleponis, J., Armstrong, T. D., Wolfgang, C. L., Jaffee, E. M., Brockstedt, D. & Zheng, L., May 22 2019, In : Journal for immunotherapy of cancer. 7, 1, 132.

    Research output: Contribution to journalArticle

    Open Access